DealsMay 7, 2026, 03:38 PM
Onconetix Enters Share Exchange Agreement with Realbotix, Simulacra
AI Summary
Onconetix, Inc. filed an S-1 registration statement, including an exhibit list detailing recent corporate activities. Key among these is a Share Exchange Agreement dated February 11, 2026, involving Onconetix, Realbotix, LLC, Realbotix Corp, and Simulacra Corporation. The filing also highlights recent capital raising efforts through the sale of Series D and E Preferred Stock and Warrants, various promissory notes, and amendments to corporate governance documents.
Key Highlights
- Share Exchange Agreement with Realbotix, Realbotix Corp, and Simulacra Corporation (Feb 11, 2026).
- Employment Agreement with Mr. David White (March 18, 2026).
- Certificate of Amendment to Certificate of Incorporation (March 25, 2026).
- First Amendment to License Agreement with Laboratory Corporation of America Holdings (Dec 6, 2025).
- Issued multiple Promissory Notes in August 2025.
- Securities Purchase Agreements for Series D and E Preferred Stock and Warrants (Sept/Oct 2025).
- Settlement Agreement and Release with Veru, Inc. (Sept 22, 2025).
Price Impact
More from ONCO